Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Beclazone Easi-Breathe to be discontinued

The manufacturer of Beclazone Easi-Breathe® (Beclometasone in a breath-actuated aerosol inhaler) has written to healthcare professionals to advise that, with effect from 30th September 2009 all strengths of these inhalers will cease to be supplied and is therefore effectively discontinued.

This step is being taken in line with existing agreements to discontinue CFC containing products in 2010. The products affected are the 50 microgram, 100 microgram and 250 microgram breath-actuated inhalers. The standard pressurised metered dose inhalers (pMDI) Beclazone will remain available until the first quarter of 2010.

There is no direct replacement for this product and patients will require a change of dose, device or steroid in order to continue treatment.

A similar device is available with the Qvar® inhaler but this drug has a smaller particle size and the dose will need reducing. There are also beclometasone containing alternatives available in different devices such as standard pMDIs or dry powder inhalers. Another option would involve changing the active ingredient to an alternative steroid such as budesonide or fluticasone.

Action: Clinicians should review affected patients and discuss the available alternatives with patients. Changing the fewest parameters (dose, device or drug) would seem prudent in order to retain patient confidence in their treatment.

Share 'Beclazone Easi-Breathe to be discontinued' on Email Share 'Beclazone Easi-Breathe to be discontinued' on Delicious Share 'Beclazone Easi-Breathe to be discontinued' on Digg Share 'Beclazone Easi-Breathe to be discontinued' on Facebook Share 'Beclazone Easi-Breathe to be discontinued' on Google+ Share 'Beclazone Easi-Breathe to be discontinued' on reddit Share 'Beclazone Easi-Breathe to be discontinued' on StumbleUpon Share 'Beclazone Easi-Breathe to be discontinued' on Twitter

atomic-wealth

2 Comments to “Beclazone Easi-Breathe to be discontinued”

  1. Jon,

    You are quite right, I have corrected the spelling in the article. Thanks.

    Comment by Matthew Robinson — June 30, 2009 #
    Reply

  2. I believe that it is spelt Beclazone Easi-Breathe if you are searching for it on GP software systems

    Comment by Jon Kerr — June 30, 2009 #
    Reply

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,620 spam comments.

atomic-wealth
fond-illness
summer